What should a pharmacist do if they identify a potential drug-allergy interaction during DUR?

When a pharmacist identifies a potential drug-allergy interaction during the Drug Utilization Review (DUR), the most appropriate action is to counsel the patient and notify the prescriber. This approach ensures patient safety by addressing the potential risk of an allergic reaction, which can be severe or life-threatening in some cases.

Counseling the patient allows the pharmacist to provide critical information about the potential interaction, the signs and symptoms of an allergic reaction, and alternative treatment options. By notifying the prescriber, the pharmacist facilitates a collaborative approach to patient care, ensuring that the prescriber can consider alternative therapies or make necessary adjustments to the medication regimen. This action is fundamental in promoting health and preventing adverse drug events.

Addressing concerns about drug-allergy interactions reflects the pharmacist’s primary responsibility to safeguard patient well-being, and it aligns with best practices established in pharmacy care.